HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Retailers’ Advances In Tracking Customer Data Push Larger Class Action Settlements

Executive Summary

Class action litigants gain larger settlements by subpoenaing retailers’ loyalty program data and customer analytics. 

You may also be interested in...



Reckitt To Pay $50M Settling Class Action Challenging Move Free Advanced Health Claims

Settlement proposed in California federal court provides cash refunds of $22 per product, up to three each, to 4.7m claimants. Products identified in complaint include Schiff Move Free Advanced, Moved Free Advanced Plus MSM and Moved Free Advanced Plus MSM & Vitamin D.

Clean Label Contaminant Study, NSF DNA Authenticated: Health And Wellness Industry News

Trade groups criticize Clean Label study; NSF testing protocol for raw botanicals; Dorothy Hamill works with Nature's Bounty as health and wellness advocate; Optimum Nutrition launches 100% Plant, s first plant-based Gold Standard whey protein powder; and more news in brief.

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel